CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net loss	$ (10,398)	$ (18,399)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,465	1,618
Amortization of deferred financing costs and debt discount	383	580
Provision for excess inventory	433	413
Allocation of issuance costs associated with warrants	343	0
Change in fair value of warrants	(1,676)	0
Share-based compensation expense	325	588
Loss on asset disposal	23	9
Increases (decreases) in cash caused by changes in operating assets and liabilities:
Accounts receivable	(316)	991
Inventories	615	457
Other current assets	514	(284)
Other assets	7	74
Accounts payable and accrued expenses	(1,274)	(1,746)
Deferred revenues	93	6
Long-term deferred rent	(24)	103
Net cash used in operating activities	(9,487)	(13,904)
Cash flows from investing activities:
Purchases of property and equipment /long-lived assets	(128)	(271)
Proceeds from sale of assets	0	10
Net cash used in investing activities	(128)	(1,462)
Cash flows from financing activities:
Principal payments on long-term obligations	0	(4,720)
Proceeds from sale of common and preferred stock, net	6,246	12,377
Net cash provided by financing activities	6,246	7,657
Effect of exchange rate changes on cash and cash equivalents	(10)	11
Net decrease in cash and cash equivalents	(3,379)	(7,698)
Cash, cash equivalents, and restricted cash at beginning of period	10,225	12,910
Cash, cash equivalents, and restricted cash at end of period	6,846	5,212
Cash paid during period for:
Interest	990	1,059
Supplemental schedule of non-cash investing and financing activities:
Conversion of preferred stock into common stock	7	0
Assets Purchased from Azaya Therapeutics, Inc. [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
In process research and development acquired from Azaya Therapeutics	0	1,686
Cash flows from investing activities:
Purchases of property and equipment /long-lived assets	0	(1,201)
Supplemental schedule of non-cash investing and financing activities:
Common stock issued in payment for the assets acquired	$ 0	$ 2,311

No definition available.

Name:	cytx_CashPaidDuringPeriodForAbstract
Namespace Prefix:	cytx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The net change in the long term deferred rent liability balance during the reporting period. Long term deferred liability is a cumulative difference between the rental payments required by a lease agreement and the rental expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in expense more than one year after the balance sheet date.

+ References

No definition available.